Latest Content


Why Fractionated Radiotherapeutic Dosing May Improve Outcomes in LM Treatment: Andrew Brenner, MD
0:25
Why Fractionated Radiotherapeutic Dosing May Improve Outcomes in LM Treatment: Andrew Brenner, MD
5 days ago
by
Sabrina McCrear(+1 more)
How Rhenium Nanoliposomes Target Leptomeningeal Metastases: Andrew Brenner, MD
0:41
How Rhenium Nanoliposomes Target Leptomeningeal Metastases: Andrew Brenner, MD
6 days ago
by
Sabrina McCrear(+1 more)
Understanding LM Therapy Across Breast Cancer Subtypes: Andrew Brenner, MD
1:11
Understanding LM Therapy Across Breast Cancer Subtypes: Andrew Brenner, MD
7 days ago
by
Sabrina McCrear(+1 more)
Antonio Urbina, MD
0:58
Changes to USAID Affected Worldwide HIV Response: Antonio Urbina, MD
14 days ago
by
Julia Bonavitacola(+1 more)
Antonio Urbina, MD
1:32
Getting Lenacapavir on Insurance Plans Is Key to Uptake: Antonio Urbina, MD
19 days ago
by
Julia Bonavitacola(+1 more)
Brian Reid, MS
1:52
DTC Models Offer Promise for Some, but Remain Limited in Scope: Brian Reid, MS
19 days ago
by
Brooke McCormick(+1 more)
Jennifer Graff, PharmD
0:53
Treatments for Symptom-Driven Conditions Are the Best Fit for DTC Models: Jennifer Graff, PharmD
20 days ago
by
Brooke McCormick(+1 more)
Ann Marie Navar, MD, PhD, headshot
0:37
Oral Pill Removes Barrier to Cholesterol-Lowering Therapy: Ann Marie Navar, MD, PhD
23 days ago
by
Laura Joszt, MA(+1 more)
Ciara Zachary, PhD, MPH
1:09
Administrative Glitches Could Leave Gaps in Care After Medicaid Work Requirements: Ciara Zachary, PhD, MPH
25 days ago
by
Julia Bonavitacola(+1 more)
William Schpero, PhD, MPhil, MPH
1:02
Millions Set to Lose Medicaid Despite Some Exceptions to Work Requirements: William Schpero, PhD, MPhil, MPH
a month ago
by
Julia Bonavitacola(+1 more)

Center on Health Equity & Access

Start seeing what truly shapes access and learn how you can redefine the landscape.

Center on Health Equity & Access



Continuing Medical Education


All News

AJMC original research clinical

A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.

Our top RSV content of 2025 included how nirsevimab and clesrovimab changed RSV prevention among younger patients, as well as the positive impact of RSV vaccination in older individuals.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo